Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

NuVasive, Inc. - Common Stock (NQ: NUVA )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NuVasive, Inc. - Common Stock

< Previous 1 2 3 Next >
Expert Ratings for NuVasive
Via Benzinga
NuVasive Earnings Preview
Via Benzinga
What 5 Analyst Ratings Have To Say About NuVasive
Via Benzinga
The Latest Analyst Ratings for NuVasive
Via Benzinga
Expert Ratings for NuVasive
Via Benzinga
Recap: NuVasive Q1 Earnings
Via Benzinga
NuVasive's Earnings: A Preview
Via Benzinga
Globus Medical Shareholders Approve Share Issuance for Merger with NuVasive
From Globus Medical
Via GlobeNewswire
Where NuVasive Stands With Analysts
Via Benzinga
Looking Into NuVasive's Return On Invested Capital
Via Benzinga
What 11 Analyst Ratings Have To Say About NuVasive
Analysts have provided the following ratings for NuVasive (NASDAQ:NUVA) within the last quarter: 
Via Benzinga
NUVASIVE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NuVasive, Inc. - NUVA
From Kahn Swick & Foti, LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NUVASIVE (Nasdaq – NUVA), Oak Street Health (NYSE – OSH), Argo Group International Holdings, Ltd. (NYSE - ARGO), Cardiovascular Systems, Inc. (Nasdaq – CSII)
From Brodsky & Smith LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NUVASIVE (Nasdaq – NUVA), Oak Street Health (NYSE – OSH), Argo Group International Holdings, Ltd. (NYSE - ARGO), Cardiovascular Systems, Inc. (Nasdaq – CSII)
From Brodsky & Smith LLC
Via GlobeNewswire
Earnings Scheduled For February 22, 2023
Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022. 
Via Benzinga
Where NuVasive Stands With Analysts
NuVasive (NASDAQ:NUVA) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Where NuVasive Stands With Analysts
Within the last quarter, NuVasive (NASDAQ:NUVA) has observed the following analyst ratings: 
Via Benzinga
NUVASIVE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NuVasive, Inc. - NUVA
From Kahn Swick & Foti, LLC
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2023
Via Benzinga
Micron Technology To Rally 20%? Here Are 10 Other Analyst Forecasts For Friday
Mizuho boosted the price target for Micron Technology, Inc. (NASDAQ: MU) from $48 to $72. Mizuho analyst Vijay Rakesh upgraded the stock from Neutral to Buy. Micron shares fell 0.3% to $59.99 in... 
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NUVASIVE (Nasdaq – NUVA), Oak Street Health (NYSE – OSH), Argo Group International Holdings, Ltd. (NYSE - ARGO), Cardiovascular Systems, Inc. (Nasdaq – CSII)
From Brodsky & Smith LLC
Via GlobeNewswire
Globus Medical-NuVasive Deal To Accelerate Globalization Strategy, Target $50B Musculoskeletal Market
Via Benzinga
NUVA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NuVasive, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off another day of trading with a look at the biggest pre-market stock movers investors need to watch for Wednesday! 
Via InvestorPlace
Allegro Microsystems, CubeSmart To Join S&P MidCap 400; ALGM Stock Set To Break Out
Allegro Microsystems and CubeSmart will join the S&P MidCap 400. 
Via Investor's Business Daily
Stocks That Hit 52-Week Lows On Thursday
  During Thursday's session, 97 companies made new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
Via Benzinga
Bristol-Myers Squibb To Surge Over 10%? Plus Morgan Stanley Predicts $263 For L3Harris Technologies
Atlantic Equities boosted the price target on Bristol-Myers Squibb Company (NYSE: BMY) from $85 to $88. Atlantic Equities analyst Steve Chesney maintained the stock with an Overweight. Bristol-Myers... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
Upgrades 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.